News

To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.

To build great products, we need a set of underlying principles grounded in hard reality. What matters most in clinical trial delivery? Is it regulatory approval? Is it patient safety? Of course, these are non-negotiable, hard requirements. But to answer our question fully, we need to take a step back to get a broader view of what is at the heart of running a clinical trial.

In this blog post, we talk about ISOs, what they are, and why they matter in the Life Sciences sector. If you're in this industry, you've likely heard the term ISO thrown around, but do you know what it really means?

Decentralised clinical trials offer many benefits such as improved patient access and enhanced recruitment, but they present unique challenges for clinical trial operations teams. This blog post article focuses on overcoming these challenges.

In recent years, the DTx market has really taken off, with new companies entering the USA every year. In this blog post, we'll introduce you to six of our favourite DTx companies making headway across the pond.

As we continue to grapple with an ever-growing demand for mental health resources, digital therapeutics have emerged as a game-changing solution. Many companies are making waves in the industry and here are some of our favourites.

Mike Pace, CEO & founder of PalmHealthCo, shares his tips on how to achieve payor reimbursement for DTx products and encourage adoption among clinicians.

From giving ancient civilisations the ability to communicate with God, to being criminalised for decades, to being at the centre-stage of a wave of new research, psychedelics have been through quite a trip of their own (excuse the pun). So, what’s their story?